Absci Company
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Investors
Technology:
Anti-infective Drugs
Industry:
AI, Early Drug Development, United States
Headquarters:
Vancouver, Washington, United States
Founded Date:
2011-01-01
Employees Number:
101-250
Funding Status:
IPO
Acquisitions Number:
2
Investors Number:
23
Total Funding:
237859989
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-03-23
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership